Wael Sumaya

532 total citations
18 papers, 380 citations indexed

About

Wael Sumaya is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Wael Sumaya has authored 18 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Wael Sumaya's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Acute Myocardial Infarction Research (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Wael Sumaya is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Acute Myocardial Infarction Research (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Wael Sumaya collaborates with scholars based in United Kingdom, Canada and United States. Wael Sumaya's co-authors include Robert F. Storey, Ramzi Ajjan, Agneta Siegbahn, Anders Himmelmänn, Lars Wallentin, Stefan James, Maria Bertilsson, Julian Gunn, Javaid Iqbal and Ever Grech and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Cochrane Database of Systematic Reviews.

In The Last Decade

Wael Sumaya

18 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wael Sumaya United Kingdom 8 269 148 93 75 38 18 380
Daniel Soffer United States 13 439 1.6× 214 1.4× 105 1.1× 85 1.1× 29 0.8× 30 508
Donald Lynch United States 11 163 0.6× 98 0.7× 36 0.4× 52 0.7× 16 0.4× 23 280
Hasan Arı Türkiye 11 444 1.7× 150 1.0× 59 0.6× 47 0.6× 24 0.6× 69 516
Mohamed Farag United Kingdom 12 323 1.2× 144 1.0× 68 0.7× 71 0.9× 13 0.3× 76 464
Gail Berman United States 6 398 1.5× 131 0.9× 124 1.3× 37 0.5× 20 0.5× 7 476
Rino Migliacci Italy 8 117 0.4× 75 0.5× 83 0.9× 48 0.6× 20 0.5× 15 284
Claudio Laudani Italy 11 278 1.0× 170 1.1× 51 0.5× 30 0.4× 10 0.3× 40 420
Maria Sara Mauro Italy 11 235 0.9× 153 1.0× 46 0.5× 31 0.4× 9 0.2× 28 372
Costin Ionescu United States 9 95 0.4× 135 0.9× 33 0.4× 89 1.2× 22 0.6× 23 293
V. Pagliara Italy 8 183 0.7× 55 0.4× 44 0.5× 56 0.7× 20 0.5× 8 297

Countries citing papers authored by Wael Sumaya

Since Specialization
Citations

This map shows the geographic impact of Wael Sumaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wael Sumaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wael Sumaya more than expected).

Fields of papers citing papers by Wael Sumaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wael Sumaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wael Sumaya. The network helps show where Wael Sumaya may publish in the future.

Co-authorship network of co-authors of Wael Sumaya

This figure shows the co-authorship network connecting the top 25 collaborators of Wael Sumaya. A scholar is included among the top collaborators of Wael Sumaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wael Sumaya. Wael Sumaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kaier, Klaus, Wael Sumaya, Daniel Duerschmied, et al.. (2024). Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. Cochrane Database of Systematic Reviews. 2024(1). CD014678–CD014678. 5 indexed citations
2.
Chen, Robert, et al.. (2023). A novel hybrid approach to correct a giant aneurysmal coronary artery fistula in an adult male patient. JTCVS Techniques. 21. 122–125. 1 indexed citations
3.
Said, S. Al, Klaus Kaier, Wael Sumaya, et al.. (2023). Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. European Heart Journal. 44(Supplement_2). 1 indexed citations
4.
Sumaya, Wael, et al.. (2022). Novel Telescope Anchoring Technique for Closure of Gigantic Coronary Fistulae Using 3-Dimensional Printing for Planning. JACC: Cardiovascular Interventions. 15(8). 896–897. 4 indexed citations
5.
6.
Alabed, Samer, Wael Sumaya, Klaus Kaier, et al.. (2021). Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. Cochrane Database of Systematic Reviews. 2 indexed citations
7.
Sumaya, Wael, William A. Parker, Heather M. Judge, et al.. (2020). Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention. Platelets. 32(4). 555–559. 5 indexed citations
8.
Sumaya, Wael, Lars Wallentin, Stefan James, et al.. (2020). Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study. Thrombosis and Haemostasis. 120(3). 412–422. 35 indexed citations
9.
Sumaya, Wael, Tobias Geisler, Steen Dalby Kristensen, & Robert F. Storey. (2019). Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?. Thrombosis and Haemostasis. 119(10). 1583–1589. 9 indexed citations
10.
Parker, William A., Patricia A. Shaw, Wael Sumaya, et al.. (2019). Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets. 30(2). 148–157. 27 indexed citations
11.
Parker, William A., et al.. (2018). ULTRA-LOW-DOSE TWICE-DAILY ASPIRIN IMPROVES HEMOSTASIS AND MAINTAINS PLATELET INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS RECEIVING TICAGRELOR. Journal of the American College of Cardiology. 71(11). A30–A30. 1 indexed citations
12.
Sumaya, Wael, William A. Parker, Ian P. Hall, et al.. (2018). Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study). Thrombosis and Haemostasis. 118(7). 1250–1256. 25 indexed citations
13.
Parker, William A., Mark R. Thomas, Heather M. Judge, et al.. (2018). Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Circulation. 138(13). 1290–1300. 55 indexed citations
14.
Sumaya, Wael, Lars Wallentin, Stefan James, et al.. (2018). Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. European Heart Journal. 39(13). 1078–1085. 117 indexed citations
15.
Sumaya, Wael & Robert F. Storey. (2016). Ticagrelor. Interventional Cardiology Clinics. 6(1). 49–55. 15 indexed citations
16.
Daly, Rebecca, Sonal Mehra, Rosemary Ecob, et al.. (2013). Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay. Thrombosis and Haemostasis. 109(3). 550–555. 7 indexed citations
17.
Iqbal, Javaid, Wael Sumaya, Yasir Parviz, et al.. (2013). Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 9(1). 62–69. 65 indexed citations
18.
Mathur, Raj & Wael Sumaya. (2007). Prevention and management of ovarian hyperstimulation syndrome. Obstetrics Gynaecology & Reproductive Medicine. 18(1). 18–22. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Soffer Breakdown of academic impact, for papers by Donald Lynch Breakdown of academic impact, for papers by Hasan Arı Breakdown of academic impact, for papers by Mohamed Farag Breakdown of academic impact, for papers by Gail Berman Breakdown of academic impact, for papers by Rino Migliacci Breakdown of academic impact, for papers by Claudio Laudani Breakdown of academic impact, for papers by Maria Sara Mauro Breakdown of academic impact, for papers by Costin Ionescu Breakdown of academic impact, for papers by V. Pagliara
Rankless by CCL
2026